Chinese Regulator Rejects Domestic PD-1/L1 Contender In Latest Tightening Signal

Past Call For More Evidence

PD-1 antibody rejection
Chinese regulator turns down home-grown PD-1/L1 antibody for first time • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia